TCL Archive Imbruvica Improves PFS, OS In Phase III CLL Study By Cancer History Project December 26, 2014
TCL Archive Blincyto Demonstrates Response In Minimal Residual Disease ALL By Cancer History Project December 26, 2014
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up By Cancer History Project December 26, 2014
TCL Archive Amgen Cancels Rilotumumab Trials in Gastric Cancer By Cancer History Project December 26, 2014
TCL Archive NCI CTEP-Approved Trials For the Month of December By Cancer History Project December 26, 2014
TCL Archive Congress Plans to Accelerate Development of Drugs, Devices By Cancer History Project December 19, 2014
TCL Archive Research Advocates Prepare to Face Republican-led Congress By Cancer History Project December 19, 2014
TCL Archive Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say By Cancer History Project December 19, 2014
